These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Inhibition of human cardiac cyclic AMP-phosphodiesterases by R 80122, a new selective cyclic AMP-phosphodiesterase III inhibitor: a comparison with other cardiotonic compounds. de Cheffoy de Courcelles D; de Loore K; Freyne E; Janssen PA J Pharmacol Exp Ther; 1992 Oct; 263(1):6-14. PubMed ID: 1328613 [TBL] [Abstract][Full Text] [Related]
45. Effect of cholecystokinin on the level of cyclic AMP and on mechanical activity in the isolated sphincter of Oddi. Andersson KE; Andersson R; Hedner P; Persson CG Life Sci I; 1972 Aug; 11(15):723-32. PubMed ID: 4347986 [No Abstract] [Full Text] [Related]
47. Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram. Souness JE; Maslen C; Webber S; Foster M; Raeburn D; Palfreyman MN; Ashton MJ; Karlsson JA Br J Pharmacol; 1995 May; 115(1):39-46. PubMed ID: 7647982 [TBL] [Abstract][Full Text] [Related]
48. Effects of various phosphodiesterase-inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro. Truss MC; Uckert S; Stief CG; Kuczyk M; Schulz-Knappe P; Forssmann WG; Jonas U Neurourol Urodyn; 1996; 15(1):59-70. PubMed ID: 8696357 [TBL] [Abstract][Full Text] [Related]
50. Correlation between cAMP in isolated frog skin epithelium and stimulation of sodium transport and osmotic water flow by antidiuretic hormone and phosphodiesterase inhibitors. Johnsen AH; Nielsen R Gen Comp Endocrinol; 1984 Apr; 54(1):144-53. PubMed ID: 6327459 [TBL] [Abstract][Full Text] [Related]
51. Quantitative aspects of cyclic AMP and relaxation in the rabbit anterior mesenteric-portal vein. Collins GA; Sutter MC Can J Physiol Pharmacol; 1975 Dec; 53(6):989-97. PubMed ID: 177162 [TBL] [Abstract][Full Text] [Related]
52. Relationship between the level of cAMP and the contractile force under stimulation of alpha- and beta-adrenoceptors by phenylephrine in the isolated rabbit papillary muscle. Endoh M; Brodde OE; Schümann HJ Naunyn Schmiedebergs Arch Pharmacol; 1976 Nov; 295(2):109-15. PubMed ID: 186721 [TBL] [Abstract][Full Text] [Related]
53. Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts. Marko D; Romanakis K; Zankl H; Fürstenberger G; Steinbauer B; Eisenbrand G Cell Biochem Biophys; 1998; 28(2-3):75-101. PubMed ID: 9515161 [TBL] [Abstract][Full Text] [Related]
54. Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone. Silver PJ; Lepore RE; O'Connor B; Lemp BM; Hamel LT; Bentley RG; Harris AL J Pharmacol Exp Ther; 1988 Oct; 247(1):34-42. PubMed ID: 2845058 [TBL] [Abstract][Full Text] [Related]
55. cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3. Beierwaltes WH Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1376-81. PubMed ID: 16449359 [TBL] [Abstract][Full Text] [Related]
56. Evaluating the significance of cyclic adenosine monophosphate-mediated signaling in human prostate: a functional and biochemical study. Kedia GT; Ückert S; Polat H; Merseburger AS; Kuczyk MA Urology; 2012 Oct; 80(4):952.e9-14. PubMed ID: 22901823 [TBL] [Abstract][Full Text] [Related]
57. Inhibition of adenosine 3',5'-monophosphate phosphodiesterase by nicotinamide and its homologues in vitro. Shimoyama M; Kawai M; Nasu S; Shioji K; Hoshi Y Physiol Chem Phys; 1975; 7(2):125-32. PubMed ID: 239431 [TBL] [Abstract][Full Text] [Related]
58. Cyclic nucleotide phosphodiesterase activity in normal and neoplastic rat mammary cells grown in monolayer culture. Cohen LA; Straka D; Chan PC Cancer Res; 1976 Jun; 36(6):2007-12. PubMed ID: 178439 [TBL] [Abstract][Full Text] [Related]